Search results
27 April 2021 - 5 mins read
Working in rare disease has taught me to better support FOP
We are delighted that this FOP Awareness Day Dr Rolf Morhart shared his invaluable insights gained through his career working in clinical practice supporting people living with the ultra-rare bone disease. Read his thoughts and reflections below....
29 August 2023 - 3 mins read
Empowering people with RCC to take more active roles in their treatment and care decisions
Despite evidence suggesting that involving people living with renal cell carcinoma (RCC) in treatment decisions can increase their overall survival and quality of life, there can be challenges to routinely embedding the Shared Decision Making (SDM) approac...
29 August 2023 - 2 mins read
Co-creating recipe guides with the kidney cancer patient community to tackle undernutrition during treatment
In France, we partnered with patient organization Association pour La Recherche sur les Tumeurs du Rein (A.R.T.u.R) and experts to help people living with kidney cancer overcome undernutrition....
12 October 2021 - 2 mins read
Reuters Events Pharma 2021: Transforming Medical Affairs to drive patient value
By Steven Hildemann, MD, PhD, EVP, Chiel Medical Officer...
17 June 2021 - 4 mins read
Ipsen launches Perspectives Matter around World Kidney Cancer Day 2021
We need to talk about how we’re feeling is the theme of World Kidney Cancer Day (WKCD) on 17 June 2021. To support this theme, Ipsen is launching Perspectives Matter; a social media campaign that brings to life the experiences and perspectives ...
18 May 2021 - 2 mins read
Ipsen’s Signes production site has received the Shingo (Gold) Award
Ipsen's Signes production site has received the Shingo (Gold) Award, the highest and most demanding distinction in operational excellence in the world....
11 October 2022 - 3 mins read
The Ixcellence Network®: celebrating 10 years of progress in improving the standard of care for patients living with debilitating neurological disorders
Continuing medical education is vital to maintaining the quality of clinical practice, which in turn can improve patient outcomes. As a pioneer in botulinum neurotoxin type A (BoNT-A) treatment, Ipsen has worked with a scientific steering committee of inte...
01 December 2020 - 2 mins read
Ipsen’s new strategic priorities unveiled at virtual Capital Markets Day event
Today, Ipsen is hosting a virtual Capital Markets Day to launch our new Group strategy which positions us for long-term success by focusing together for patients and society. Four priorities will drive continued growth and bring transformative medicines to...
28 October 2020 - 2 mins read
Liver Cancer Awareness Month – Rethink liver cancer
October is Liver Cancer Awareness Month and this year we are proud to be supporting the European Liver Patients Association (ELPA) with their campaign encouraging everyone to rethink liver cancer by bringing it to the forefront of conversations....